DNA samples of thousands of suspected terrorists from Iraq, Afghanistan and elsewhere have been collected and preserved in a little-known U.S. government database that is intended for forensic intelligence and counterterrorism purposes.
As of 2005, seven thousand detainee samples had been processed into the Joint Federal Agencies Antiterrorism DNA Database. Ten thousand more were “inbound” at that time from Iraq and Afghanistan, according to a public presentation. See “The Department of Defense DNA Registry and the U.S. Government Accounting Mission” (pdf) by Brion C. Smith, August 2005 (at page 14).
The Joint Federal Agencies Antiterrorism DNA Database working group is comprised of representatives of the Department of Defense, the FBI and the U.S. intelligence community.
Disclosure of DNA and other medical information for intelligence purposes is explicitly authorized by government regulations.
“Under U.S. and international law, there is no absolute confidentiality of medical information for any person, including detainees,” according to the new DoD directive 3115.09 (pdf) on intelligence interrogation. “Medical information may be released for all lawful purposes… including release for any lawful intelligence or national security-related purpose.”
Update: See, relatedly, this new report from the Government Accountability Office, which curiously refrains from mentioning the term “DNA”: DOD Can Establish More Guidance for Biometrics Collection and Explore Broader Data Sharing (pdf), GAO-09-49, October 2008.
With targeted policy interventions, we can efficiently and effectively support the U.S. innovation economy through the translation of breakthrough scientific research from the lab to the market.
Crowd forecasting methods offer a systematic approach to quantifying the U.S. intelligence community’s uncertainty about the future and predicting the impact of interventions, allowing decision-makers to strategize effectively and allocate resources by outlining risks and tradeoffs in a legible format.
The energy transition underway in the United States continues to present a unique set of opportunities to put Americans back to work through the deployment of new technologies, infrastructure, energy efficiency, and expansion of the electricity system to meet our carbon goals.
The United States has the only proven and scalable tritium production supply chain, but it is largely reserved for nuclear weapons. Excess tritium production capacity should be leveraged to ensure the success of and U.S. leadership in fusion energy.